Search

everythinglearnresearchcommunity

for

Search:↓

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Balding men have higher heart disease risk.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Non-obese women with hair loss have higher heart disease risk.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

INVERSION Femme supplement helped women lose weight, reduce hair loss, and improve skin and nail health.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

CBD can either promote or inhibit hair growth depending on the concentration used.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Some alternative therapies for vitiligo show promise but need more research.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.